Prostate cancer — all decisions

The Board remands the claims for service connection for prostate cancer, NHL, hypothyroidism, DM II, and an acquired psychiatric disorder to correct a duty to assist error that occurred prior to the October 2024 rating decision.

The Board denied increased ratings for prostate cancer residuals, upper and trunk scars but granted a total disability rating based on individual unemployability due to service-connected disabilities.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on aid and attendance, finding that he does not meet the criteria due to his service-connected disabilities.

The Board denied the Veteran's claim for an increased, compensable disability evaluation for his service-connected prostate cancer.

The Veteran withdrew his appeal for service connection for erectile dysfunction, prostate cancer, hearing loss, tinnitus, diabetes mellitus, PTSD, sleep apnea, and vision loss.

The Board remands the claims for service connection due to a duty to assist error that occurred prior to the respective rating decisions on appeal.

The Board denied a higher rating for prostate cancer residuals and granted an effective date of January 26, 2021, for the grant of TDIU and DEA.

The Board remands the claims for an earlier effective date for prostate cancer, erectile dysfunction as secondary to prostate cancer, and special monthly compensation (SMC) based on the loss of use of a creative organ due to a pre-decisional duty to assist error.

The Board remands the claims for service connection for prostate cancer and chronic lymphocytic lymphoma leukemia (CLL) to verify the Veteran's National Guard service dates and obtain medical opinions regarding a possible link between exposure to commercial herbicides and these conditions.

The Board granted service connection for prostate cancer and diabetes mellitus type 2 based on the Veteran's presumed exposure to herbicide agents during service.

The Board denied service connection for prostate cancer and diabetes, finding no evidence of a causal relationship between the conditions and active-duty service or toxic herbicide exposure.

The Board denied the claims for service connection for prostate cancer and diabetes mellitus, type II due to a lack of evidence supporting exposure to herbicide agents during service.

The Veteran's service-connected prostate cancer, alone, precluded him from securing or following a substantially gainful occupation and he is entitled to a total disability rating based on individual unemployability (TDIU) effective April 13, 2022. Additionally, the Veteran is also granted special monthly compensation (SMC) at the housebound rate effective April 13, 2022.

The Board denied service connection for prostate cancer and a higher disability rating for the left ankle disability.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that the evidence does not support a causal relationship between his in-service exposure to PCBs and his current condition.

The Board remands the case to obtain an addendum opinion addressing whether the Veteran's prostate cancer is related to in-service exposures to firefighting foam and asbestos.

The Board granted service connection for diabetes mellitus as secondary to service-connected hypertension and denied a compensable rating for erectile dysfunction, while remanding claims for higher ratings and additional service connections.

The appeal of the issue of entitlement to service connection for prostate cancer is dismissed due to the Veteran's death.

The Board denied service connection for prostate cancer and remanded claims for bronchitis and emphysema due to potential exposure to jet fuel fumes.

The Board remands the case to obtain an opinion on whether the Veteran's prostate cancer is related to his military service under another basis besides presumptively under the PACT Act.